CUSIP: 38000Q102
Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
14,070,204
-
Share change
-
+14,070,204
-
Total reported value
-
$229,767,000
-
Price per share
-
$16.33
-
Number of holders
-
36
-
Value change
-
+$229,767,000
-
Number of buys
-
36
Security key
38000Q102
Report period
Q1 2014
Institutions
36
Top holders
10
Reporting periods
Holder history for CUSIP 38000Q102
Recent filing periods:
Top shareholders of GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2014
As of 31 Mar 2014,
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,070,204 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT CO LLP, FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, WALL STREET ASSOCIATES, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
36
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q1 2014 vs Q3 2025 Across Filers
| Investor |
Q3 2025 Shares |
Q1 2014 Shares |
Share Diff |
Share Chg % |
Q3 2025 Value $ |
Q1 2014 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.